Can I Take Berberine with PT-141 (Bremelanotide)?
Clinical review of berberine and bremelanotide (PT-141) co-use, covering CYP3A4 inhibition, blood pressure interactions, dose-separation strategy, and monitoring guidance.
13 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 13 of 13 clinical reviews.
Clinical review of berberine and bremelanotide (PT-141) co-use, covering CYP3A4 inhibition, blood pressure interactions, dose-separation strategy, and monitoring guidance.
A guide to the calcium and PT-141 (bremelanotide) interaction, covering pharmacokinetics, cardiovascular monitoring, dosing windows, and safety evidence.
Evidence-based guide on combining CoQ10 supplements with PT-141 (bremelanotide). Covers pharmacokinetic and pharmacodynamic interactions, dose-separation strategies, blood pressure monitoring, and clinical guidance for safe co-administration.
A guide to combining green tea extract (EGCG) and PT-141 (Bremelanotide): pharmacokinetic interactions, hepatotoxicity risk, dosing windows, and monitoring recommendations backed by primary literature.
A guide to the L-theanine and PT-141 (bremelanotide) interaction: mechanism, safety, dosing windows, and monitoring advice backed by primary literature.
A guide to combining melatonin with PT-141 (bremelanotide), covering known interactions, pharmacokinetic overlap, glucose tolerance effects, dose-timing strategies, and monitoring recommendations.
A clinical review of the pharmacokinetic and pharmacodynamic interaction between bremelanotide (PT-141) and omega-3 fatty acids (EPA/DHA), including bleeding risk, triglyceride effects, dosing windows, and monitoring guidance.
A guide to the pharmacokinetic and pharmacodynamic interactions between quercetin and PT-141 (bremelanotide), including dose-separation windows, monitoring guidance, and when to call your prescriber.
Evidence-based guide on reishi mushroom and PT-141 (bremelanotide) interactions, covering pharmacokinetic and pharmacodynamic concerns, dose-separation strategies, and monitoring recommendations.
Evidence-based guide on taking rhodiola rosea with PT-141 (bremelanotide). Covers pharmacokinetic and pharmacodynamic interaction risks, dose-separation strategies, monitoring parameters, and what to do if you already use both.
St. John's Wort is a potent CYP3A4 inducer that may reduce bremelanotide exposure. Learn about the pharmacokinetic interaction, dose-separation options, monitoring, and what to do if you already take both.
A guide to the turmeric/curcumin and PT-141 (bremelanotide) interaction, covering pharmacokinetics, anticoagulant risk, dosing windows, and monitoring recommendations.
A clinical review of the interaction between vitamin D supplementation and PT-141 (bremelanotide), covering pharmacokinetics, safety, dosing, and monitoring recommendations.